Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Cameron R. Wolfe, Anabela Cardoso, Diego López de Castilla et al.|The Lancet Respiratory Medicine|2022

Cited by 128